Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

957
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
957
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.3K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.3K
Cancer Vaccines01:30

Cancer Vaccines

324
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
324

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of risk profiles among persons attending a sexually transmitted infection clinic in Estonia.

PloS one·2026
Same author

Factors associated with women's choice for mode of cervical sampling in future cervical cancer screening.

PloS one·2026
Same author

Transformative public health education - are we there, yet?

Public health reviews·2026
Same author

Increasing incidence and severity of childhood-onset type 1 diabetes in Latvia during the COVID-19 pandemic.

Frontiers in pediatrics·2026
Same author

Co-creation of a mobile health program (MumCare) for preventing maternal cardiovascular disease after pregnancy complications.

Frontiers in global women's health·2026
Same author

Unstructured spare time as an international predictor of adolescent crime.

PloS one·2026

Related Experiment Video

Updated: May 24, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Navigating the risks: Stakeholder views on risk-based cervical cancer screening.

Maali-Liina Remmel1, Kadri Suija1,2, Anna Markina3

  • 1Institute of Family Medicine and Public Health, Faculty of Medicine, University of Tartu, Tartu, Estonia.

Plos One
|March 5, 2025
PubMed
Summary

Stakeholders in Estonia support risk-based cervical cancer screening (RB CCS) but cite concerns regarding system readiness and complexity. Further evidence, infrastructure development, and public engagement are vital for successful implementation.

More Related Videos

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

201

Related Experiment Videos

Last Updated: May 24, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

201

Area of Science:

  • Oncology
  • Public Health Policy
  • Health Services Research

Background:

  • Implementing risk-based cancer screening necessitates changes in healthcare practices and policies.
  • Assessing the effectiveness and acceptability of new screening technologies and risk models is crucial.
  • This study evaluates the acceptability of risk-based cervical cancer screening (RB CCS) in Estonia among key stakeholders.

Purpose of the Study:

  • To assess the acceptability of risk-based cervical cancer screening (RB CCS) in Estonia.
  • To understand stakeholder perspectives on the feasibility and challenges of implementing RB CCS.

Main Methods:

  • Qualitative study utilizing semi-structured interviews with 17 stakeholders in Estonia.
  • Interviews guided by the Theoretical Framework of Acceptability.
  • Framework analysis based on the Consolidated Framework for Implementation Research.

Main Results:

  • Stakeholders generally favor RB CCS for improved outcomes and resource allocation.
  • Significant concerns were raised regarding system readiness, complexity, and ethical issues.
  • Need for validated models, public communication, provider training, and collaboration was emphasized.

Conclusions:

  • Favorable stakeholder attitudes provide a foundation for advancing RB CCS.
  • A strategy focusing on evidence generation, infrastructure, patient empowerment, and collaboration is essential.
  • Addressing feasibility and ethical concerns is critical for successful implementation.